Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Non-Current Assets: 2011-2019

Historic Other Non-Current Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $150,000.

  • EyePoint Pharmaceuticals' Other Non-Current Assets changed negligibly% to $150,000 in Q1 2019 from the same period last year, while for Mar 2019 it was $150,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $150,000 for FY2018, which is negligibly% changed negligibly from last year.
  • As of Q1 2019, EyePoint Pharmaceuticals' Other Non-Current Assets stood at $150,000, which was down 0.00% from $150,000 recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Other Non-Current Assets high stood at $150,000 for Q1 2015, and its period low was $150,000 during Q1 2015.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Other Non-Current Assets value was $150,000 (recorded in 2019), while the average stood at $150,000.
  • Data for EyePoint Pharmaceuticals' Other Non-Current Assets shows a maximum YoY declined of 15.25% (in 2015) over the last 5 years.
  • Over the past 5 years, EyePoint Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $150,000 in 2015, then remained steady at $150,000 in 2016, then remained steady at $150,000 in 2017, then remained steady at $150,000 in 2018, then remained steady at $150,000 in 2019.
  • Its last three reported values are $150,000 in Q1 2019, $150,000 for Q4 2018, and $150,000 during Q3 2018.